Loading...
NEWS & PRESS2024-07-02T16:16:07+00:00

Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND™ Trans-Septal System

HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 /PRNewswire/ -- Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND™ Trans-Septal System for investigational device exemption (IDE) application to commence an Early Feasibility Study (EFS). The AMEND™ Trans-Septal [...]

Go to Top